Ferric Maltol Suggested as Promising New Therapy for Iron Deficiency Anemia in ‪#IBD‬ Patients

Ferric Maltol Suggested as Promising New Therapy for Iron Deficiency Anemia in ‪#IBD‬ Patients
PillA multicenter phase-3 clinical trial study published in the journal Inflammatory Bowel Diseases, revealed that ferric maltol, a ferric iron compound, has the potential to be used as a new oral treatment for iron deficiency anemia in patients with inflammatory bowel disease (IBD). The study is entitled “Ferric Maltol Is Effective in Correcting Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: Results from a Phase-3 Clinical Trial Program”. IBD is a chronic inflammatory condition of the digestive tract that primarily comprises Crohn’s disease and ulcerative colitis. IBD can, in certain circumstances, lead to life-threatening complications, such as iron deficiency anemia. In the study, led by Dr. Christoph Gasche from the Medical University of Vienna, two similar randomized, double blind clinical trials were performed comprising several centers in the United Kingdom, Germany, Austria a
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *